132 related articles for article (PubMed ID: 8544060)
21. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
[TBL] [Abstract][Full Text] [Related]
22. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.
Gazzinelli RT; Wysocka M; Hieny S; Scharton-Kersten T; Cheever A; Kühn R; Müller W; Trinchieri G; Sher A
J Immunol; 1996 Jul; 157(2):798-805. PubMed ID: 8752931
[TBL] [Abstract][Full Text] [Related]
23. Exacerbation of toxoplasmosis in neutrophil-depleted mice.
Sayles PC; Johnson LL
Nat Immun; 1996-1997; 15(5):249-58. PubMed ID: 9390274
[TBL] [Abstract][Full Text] [Related]
24. Heat shock protein 65 induced by gammadelta T cells prevents apoptosis of macrophages and contributes to host defense in mice infected with Toxoplasma gondii.
Hisaeda H; Sakai T; Ishikawa H; Maekawa Y; Yasutomo K; Good RA; Himeno K
J Immunol; 1997 Sep; 159(5):2375-81. PubMed ID: 9278328
[TBL] [Abstract][Full Text] [Related]
25. Inducible nitric oxide synthase is not required for long-term vaccine-based immunity against Toxoplasma gondii.
Khan IA; Matsuura T; Kasper LH
J Immunol; 1998 Sep; 161(6):2994-3000. PubMed ID: 9743363
[TBL] [Abstract][Full Text] [Related]
26. Major role for CD8 T cells in the protection against Toxoplasma gondii following dendritic cell vaccination.
Guiton R; Zagani R; Dimier-Poisson I
Parasite Immunol; 2009 Oct; 31(10):631-40. PubMed ID: 19751475
[TBL] [Abstract][Full Text] [Related]
27. In pregnant mice, the infection of Toxoplasma gondii causes the decrease of CD4+CD25+ -regulatory T cells.
Ge YY; Zhang L; Zhang G; Wu JP; Tan MJ; Hu E; Liang YJ; Wang Y
Parasite Immunol; 2008 Sep; 30(9):471-81. PubMed ID: 18627509
[TBL] [Abstract][Full Text] [Related]
28. Infection of mice lacking the common cytokine receptor gamma-chain (gamma(c)) reveals an unexpected role for CD4+ T lymphocytes in early IFN-gamma-dependent resistance to Toxoplasma gondii.
Scharton-Kersten T; Nakajima H; Yap G; Sher A; Leonard WJ
J Immunol; 1998 Mar; 160(6):2565-9. PubMed ID: 9510152
[TBL] [Abstract][Full Text] [Related]
29. IL-15-induced CD8+CD122+ T cells increase antibacterial and anti-tumor immune responses: implications for immune function in aged mice.
Motegi A; Kinoshita M; Inatsu A; Habu Y; Saitoh D; Seki S
J Leukoc Biol; 2008 Oct; 84(4):1047-56. PubMed ID: 18653461
[TBL] [Abstract][Full Text] [Related]
30. Infection with Toxoplasma gondii reduces established and developing Th2 responses induced by Nippostrongylus brasiliensis infection.
Liesenfeld O; Dunay IR; Erb KJ
Infect Immun; 2004 Jul; 72(7):3812-22. PubMed ID: 15213122
[TBL] [Abstract][Full Text] [Related]
31. In vivo study of toxoplasmic parasitemia using interferon-gamma-deficient mice: absolute cell number of leukocytes, parasite load and cell susceptibility.
Norose K; Naoi K; Fang H; Yano A
Parasitol Int; 2008 Dec; 57(4):447-53. PubMed ID: 18585475
[TBL] [Abstract][Full Text] [Related]
32. Mediation of immunity to Toxoplasma gondii oocyst shedding in cats.
Davis SW; Dubey JP
J Parasitol; 1995 Dec; 81(6):882-6. PubMed ID: 8544058
[TBL] [Abstract][Full Text] [Related]
33. Gamma interferon-dependent temporary resistance to acute Toxoplasma gondii infection independent of CD4+ or CD8+ lymphocytes.
Johnson LL; VanderVegt FP; Havell EA
Infect Immun; 1993 Dec; 61(12):5174-80. PubMed ID: 7901163
[TBL] [Abstract][Full Text] [Related]
34. Aging and the immune response. I. Antibody formation and chronic infection in Toxoplasma gondii-infected mice.
Gardner ID; Remington JS
J Immunol; 1978 Mar; 120(3):939-43. PubMed ID: 632593
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii.
Tato CM; Villarino A; Caamaño JH; Boothby M; Hunter CA
J Immunol; 2003 Mar; 170(6):3139-46. PubMed ID: 12626571
[TBL] [Abstract][Full Text] [Related]
36. [Experimental study on the in vitro resistance to Toxoplasma gondii by murine lymphocyte].
Shi Q; Hao BH; Zhou YL; Shi XM; Yang AN; Zhang J; Cheng YB; Li Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):493-5. PubMed ID: 15169667
[TBL] [Abstract][Full Text] [Related]
37. Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites.
Gazzinelli RT; Denkers EY; Sher A
Infect Agents Dis; 1993 Jun; 2(3):139-49. PubMed ID: 7909708
[TBL] [Abstract][Full Text] [Related]
38. Neurotoxicity and immunotoxicity assessment in CBA/J mice with chronic Toxoplasma gondii infection and multiple oral exposures to methylmercury.
King MD; Lindsay DS; Holladay S; Ehrich M
J Parasitol; 2003 Aug; 89(4):856-9. PubMed ID: 14533705
[TBL] [Abstract][Full Text] [Related]
39. CR3-dependent resistance to acute Toxoplasma gondii infection in mice.
Johnson LL; Gibson GW; Sayles PC
Infect Immun; 1996 Jun; 64(6):1998-2003. PubMed ID: 8675299
[TBL] [Abstract][Full Text] [Related]
40. Intact immune defenses are required for mice to resist the ts-4 vaccine strain of Toxoplasma gondii.
Sayles PC; Johnson LL
Infect Immun; 1996 Aug; 64(8):3088-92. PubMed ID: 8757838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]